Center for iPS Cell Research and Application (CiRA)

A New Method to Achieve Precise Gene Editing in Embryos ― Reducing Variability through AI Prediction ―

Charting the path to human airway multiciliated cells

BIVID‑MaPPing hidden RNA-small molecule interactions

Unlocking the Antimicrobial Potential of iPSC‑Derived Platelets

Disrupting pathogenic cell states to combat pulmonary fibrosis

Pinpointing TAF4B's critical contribution to blood lineage specification

Uncovering lineage-specific differences in iPS cell-derived MSCs

Delivering genome editing components with Lipid Nanoparticles to repair the building blocks of muscles

Global Engagement

Establishment of two new On-site Laboratories approved

Integrating multi-scale analyses to reveal FGFR1 inhibition as a strategy against cardiac fibrosis

Development of a highly efficient method for generating iPS cells from human peripheral blood cells

Recreating human thymus development in a dish using iPS cells

Demonstrating immune tolerance of allogeneic iPS cell-derived neural transplants

Demonstrating immune tolerance of allogeneic iPS cell-derived neural transplants

Predicting stem cell-derived organoid quality with machine learning

Inhibiting STAT1 Boosts Platelet Production via LIN28A-let-7 Control

Streamlining Differentiation with Non-Destructive AI-Based Imaging